CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishA general and efficient three-step procedure for the highly regioselective synthesis of 1-methyl-1H-imidazoles possessing electron-rich, electron-neutral and/or electron-deficient aryl moieties at their 4- and 5-position is described. The first step involves the Pd-catalyzed direct C-5 arylation of commercially available 1-methyl-1H-imidazole with aryl bromides and the second and third step of the sequence involve the selective C-4 bromination of the resulting 5-aryl-1-methyl-1H-imidazoles with NBS followed by a PdCl2(dppf)-catalyzed Suzuki-type reaction between 5-aryl-4-bromo-1-methyl-1H-imidazoles and arylboronic acids under phase-transfer conditions. Two so prepared 4,5-diaryl-1-methyl-1H-imidazoles, which can be regarded as Z-restricted analogues of naturally-occurring combretastatin A-4 (CA-4), have proven to be highly cytotoxic against a variety of human tumor cell lines and one of these derivatives has been shown to be more cytotoxic than CA-4 and all of the imidazole derivatives investigated in the literature so far.
| Autori interni: | |
| Autori: | Bellina, Fabio; Cauteruccio, Silvia; DI FIORE ANNA, ; Rossi, Renzo |
| Titolo: | Regioselective Synthesis of 4,5-Diaryl-1-methyl-1H-imidazoles Including Highly Cytotoxic Derivatives by Pd-Catalyzed Direct C-5 Arylation of 1-Methyl-1H-imidazole with Aryl Bromides |
| Anno del prodotto: | 2008 |
| Abstract: | A general and efficient three-step procedure for the highly regioselective synthesis of 1-methyl-1H-imidazoles possessing electron-rich, electron-neutral and/or electron-deficient aryl moieties at their 4- and 5-position is described. The first step involves the Pd-catalyzed direct C-5 arylation of commercially available 1-methyl-1H-imidazole with aryl bromides and the second and third step of the sequence involve the selective C-4 bromination of the resulting 5-aryl-1-methyl-1H-imidazoles with NBS followed by a PdCl2(dppf)-catalyzed Suzuki-type reaction between 5-aryl-4-bromo-1-methyl-1H-imidazoles and arylboronic acids under phase-transfer conditions. Two so prepared 4,5-diaryl-1-methyl-1H-imidazoles, which can be regarded as Z-restricted analogues of naturally-occurring combretastatin A-4 (CA-4), have proven to be highly cytotoxic against a variety of human tumor cell lines and one of these derivatives has been shown to be more cytotoxic than CA-4 and all of the imidazole derivatives investigated in the literature so far. |
| Digital Object Identifier (DOI): | 10.1002/ejoc.200800738 |
| Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
http://hdl.handle.net/11568/206055
Copyright © 2021